CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,048 | -21.4% | 98,024 | +37.8% | 0.00% | – |
Q2 2023 | $85,354 | +19842.5% | 71,128 | +19333.9% | 0.00% | – |
Q1 2023 | $428 | -57.2% | 366 | -67.7% | 0.00% | – |
Q2 2022 | $1,000 | -97.7% | 1,132 | -95.3% | 0.00% | – |
Q1 2022 | $43,000 | -71.3% | 24,231 | -75.2% | 0.00% | – |
Q4 2021 | $150,000 | +30.4% | 97,692 | +72.1% | 0.00% | – |
Q3 2021 | $115,000 | -29.9% | 56,762 | +20.5% | 0.00% | – |
Q2 2021 | $164,000 | -18.4% | 47,093 | -58.3% | 0.00% | – |
Q1 2021 | $201,000 | +93.3% | 112,993 | +10.6% | 0.00% | – |
Q4 2020 | $104,000 | +1055.6% | 102,182 | +1214.4% | 0.00% | – |
Q2 2020 | $9,000 | +125.0% | 7,774 | +113.2% | 0.00% | – |
Q2 2019 | $4,000 | +300.0% | 3,647 | +448.4% | 0.00% | – |
Q4 2018 | $1,000 | -83.3% | 665 | -74.1% | 0.00% | – |
Q2 2018 | $6,000 | -64.7% | 2,572 | -53.6% | 0.00% | – |
Q1 2018 | $17,000 | +183.3% | 5,545 | +268.4% | 0.00% | – |
Q4 2017 | $6,000 | 0.0% | 1,505 | -20.3% | 0.00% | – |
Q3 2017 | $6,000 | – | 1,889 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
Ergoteles LLC | 451,890 | $416,000 | 0.01% |
Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |